Product NDC: | 46287-015 |
Proprietary Name: | Amantadine Hydrochloride |
Non Proprietary Name: | amantadine hydrochloride |
Active Ingredient(s): | 50 mg/5mL & nbsp; amantadine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 46287-015 |
Labeler Name: | Carolina Medical Products Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075819 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020911 |
Package NDC: | 46287-015-01 |
Package Description: | 473 mL in 1 BOTTLE (46287-015-01) |
NDC Code | 46287-015-01 |
Proprietary Name | Amantadine Hydrochloride |
Package Description | 473 mL in 1 BOTTLE (46287-015-01) |
Product NDC | 46287-015 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | amantadine hydrochloride |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20020911 |
Marketing Category Name | ANDA |
Labeler Name | Carolina Medical Products Company |
Substance Name | AMANTADINE HYDROCHLORIDE |
Strength Number | 50 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |